Video

Personalized Cancer Care Plans in the Age of "Dr. Google"

Ann Culkin, R.N., O.C.N, an oncology nurse at Memorial Sloan Kettering Cancer Center, discusses the importance of patient-centered care in the age of the internet.

Ann Culkin, R.N., O.C.N, an oncology nurse at Memorial Sloan Kettering Cancer Center, discusses the importance of patient-centered care in the age of the internet.

Culkin generally asks worried patients and their loved ones to stay off the internet, because "Dr. Google," a term referring to diagnoses and information patients get from search engines, can often create worry and fear. To mitigate this, it is imperative to revert back to personalized medicine and helping patients understand their individual diagnosis.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man with text.
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.
Terry Gillespie said the hardest parts of her cancer journey were the isolation, the impact of chemotherapy, and how unprepared she felt despite good guidance.
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Outpatient CAR T-cell therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.